These put forward that ZNF320 may serve as a target for early clinical diagnosis and treatment which may have a chance to improve diagnostic and therapeutic options, and at the same time provides a reference for further exploration of new cancer immunotherapy. The gene discussed is ZNF320; the disease is cancer.